Over the past 12 months, 0 insiders at Reneo Pharmaceuticals, Inc. filed 0 open-market SEC Form 4 transactions on RPHM: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 25, 24 | Braden Michael LeonardTenPercentOwner | BUY | 68.7K | $1.50 | $103K |
| Sep 24, 24 | Braden Michael LeonardTenPercentOwner | BUY | 29.6K | $1.41 | $42K |
| Sep 18, 24 | Braden Michael LeonardTenPercentOwner | BUY | 806 | $1.40 | $1K |
| Sep 17, 24 | Braden Michael LeonardTenPercentOwner | BUY | 55.3K | $1.36 | $75K |
| Sep 16, 24 | Braden Michael LeonardTenPercentOwner | BUY | 172.7K | $1.37 | $237K |
| Sep 13, 24 | Braden Michael LeonardTenPercentOwner | BUY | 150.0K | $1.31 | $197K |
| Sep 12, 24 | Braden Michael LeonardTenPercentOwner | BUY | 36.2K | $1.40 | $51K |
| Aug 14, 24 | Braden Michael LeonardTenPercentOwner | BUY | 100.5K | $1.41 | $142K |
| Aug 13, 24 | Braden Michael LeonardTenPercentOwner | BUY | 171.3K | $1.39 | $238K |
| May 14, 24 | Braden Michael LeonardTenPercentOwner | BUY | 335.0K | $1.56 | $516K |
| Aug 28, 23 | Ashley HallChief Development Officer | SELL | 15.6K | $6.28 | $98K |
| Jun 23, 23 | Novo Holdings A/sTenPercentOwner | SELL | 100.0K | $7.10 | $710K |
| May 8, 23 | Niall O'DonnellDirector | BUY | 125.0K | $8.00 | $1.0M |
| Sep 1, 22 | Michael CruseChief Operating Officer | BUY | 7.5K | $3.39 | $25K |
| Aug 31, 22 | Michael CruseChief Operating Officer | BUY | 3.2K | $3.21 | $10K |
| Aug 30, 22 | Michael CruseChief Operating Officer | BUY | 1.8K | $3.19 | $6K |
| Aug 29, 22 | Michael CruseChief Operating Officer | BUY | 1.1K | $3.24 | $4K |
| Aug 25, 21 | Michael CruseSenior VP-Corporate Operations | BUY | 2.5K | $7.45 | $19K |
| Aug 25, 21 | Gregory J. FlesherPresident and CEO | BUY | 8.0K | $8.00 | $64K |
| Aug 25, 21 | Vineet R. JindalChief Financial Officer | BUY | 5.0K | $7.44 | $37K |
Over the past 12 months, insiders at Reneo Pharmaceuticals, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on RPHM, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market RPHM insider purchase in our data was $1.0M by Niall O'Donnell, Director, filed on May 8, 23.
0 different insiders at Reneo Pharmaceuticals, Inc. filed open-market SEC Form 4 transactions on RPHM over the last 12 months.
InsiderTape plots every RPHM insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Reneo Pharmaceuticals, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →